GLP-1 medicines reduce the mental preoccupation with food that many people don't even recognize as excessive until it's suddenly diminished
But the speed and extent of reversal can vary from person to person
A health problem of this magnitude requires significant commitment and resources to address, and we believe that patients will be best served with Carmots pipeline backed by the drug development expertise, extensive resources and worldwide reach of Roche, Tim Kutzkey, PhD, chair of Carmots board of directors, said in a statement
Retardando el vaciamiento gstrico, lo que suaviza los picos de glucosa tras las comidas
Recent advancementsincluding the approval of oral semaglutide (Rybelsus)have demonstrated the potential for effective oral peptide delivery, though such formulations still face significant pharmacokinetic and formulation-related challenges